Home Current Issue Previous Issues Published Ahead-of-Print Supplements Collections Podcasts Video Journal Info
Skip Navigation LinksHome > May 2011 - Volume 68 - Issue 5 > Packed Red Blood Cell Transfusion and Decreased Mortality in...
Neurosurgery:
doi: 10.1227/NEU.0b013e31820cccb2
Research-Human-Clinical Studies

Packed Red Blood Cell Transfusion and Decreased Mortality in Intracerebral Hemorrhage

Sheth, Kevin N MD*; Gilson, Aaron J BA‡; Chang, Yuchiao PhD§; Kumar, Mona A MD#; Rahman, Rosanna M PhD‡; Rost, Natalia S MD‖; Schwab, Kristin BA‡; Cortellini, Lynelle BA‡; Goldstein, Joshua N MD, PhD¶; Smith, Eric E MD, MPH**; Greenberg, Steven M MD, PhD‖; Rosand, Jonathan MD, MSc‡‖

Press Release
Collapse Box

Abstract

BACKGROUND: Accumulating data suggest that anemia worsens outcomes in critically ill patients, including those with subarachnoid and intracerebral hemorrhage (ICH). Although packed red blood cell (PRBC) transfusion appears to increase brain tissue oxygen, it is unknown whether such transfusions, which are commonly administered in patients with intracranial hemorrhage, alter outcome.

OBJECTIVE: Following up on our observation that anemia is associated with poor outcome in patients with ICH, we investigated whether PRBC transfusion was associated with any benefit.

METHODS: Five hundred forty-six consecutive subjects were identified from an ongoing single-center, prospective cohort study of nontraumatic ICH over a 6-year period. Clinical and radiographic characteristics, laboratory values including admission and daily mean hemoglobin values, and all instances of PRBC transfusion were recorded. Aggressiveness of care was assessed by whether the patient had a “do not resuscitate” order activated during hospitalization. The primary endpoint was 30-day survival.

RESULTS: Anemia was present in 144 of 546 patients (26%) on admission and developed subsequently in an additional 250, leaving just 152 of 546 patients (28%) who never developed anemia. PRBC transfusion was administered to 100 patients (18%) during their hospital stay, 98% of whom were anemic. In multivariable analysis, PRBC transfusion was associated with improved survival at 30 days (odds ratio: 2.76; 95% confidence interval: 1.45-5.26; P = .002).

CONCLUSION: Anemia develops in the majority of patients with ICH at some point during their hospitalization. PRBC transfusion was associated with improved outcome in these patients.

Copyright © by the Congress of Neurological Surgeons

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.